CNBC's David Faber and Jim Cramer discuss the influence of activist investors on corporate America as Hertz and Darden come under pressure from Carl Icahn and Starboard Value.» Read More
Here’s our Fast Money Final Trade. Instead of stock picks our gang gives you their thoughts on the brave new world that comes after the election.
Ahead of the election, you should know Carl Icahn has a few concerns.
Carl Icahn might be a lot of things, but shy isn’t one of them. If there’s something he doesn’t like, expect to hear about. And there’s something he doesn’t like.
Carl Icahn's recent increased investment in Lions Gate shares isn't the only news resulting from the company's low stock price. On October 10 the stock dipped below $6, triggering a margin call by Merrill Lynch for Vice Chairman Michael Burns, selling 672,000 shares of his stock, 49 percent of his stake in the company, recorded in a Form 4 filed on October 14.
Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!
If there’s one billionaire investor you don’t want to aggravate its Carl Icahn. What makes us say that? He’s aggravated. Really aggravated. Wait till you see what’s got him going.
We couldn’t talk with legendary investor Carl Icahn and not ask about his portfolio. Here’s what’s got his attention these days.
Fed up with the back room wheeling and dealing on Wall Street? Now you can do something about it, thanks to Carl Icahn.
ImClone Chairman Carl Icahn says latest Bristol Myers offer is "absurd!"
I've been under the weather and too lethargic to even blog for a couple days, but nuthin' like a good ol' fashioned corporate war of words to get me goin' again.
"What we’ve really seen over the last three or four years is greed gone wild, and now we’re paying the price for it in a monster hangover..."
Carl Icahn is angry and when the Queens-born billionaire gets angry, he also gets rich. In an exclusive interview find out why companies may be much worse than you think!
Billionaire investor Carl Icahn reported that he had increased his stake in Motorola to 144.1 million shares from 115.6 million shares the prior quarter. Meanwhile, George Soros raised his stake in Wall Street firm Lehman Brothers to 9.5 million shares.
Biotechnology company ImClone Systems, which rebuffed a $60-per-share takeover offer from Bristol-Myers Squibb, said on Thursday it hired JP Morgan Chase as its financialadviser.
Video rental company Blockbuster posted a second quarter loss of $44.7 million, or 23 cents per share, compared to an 18 cent-per-share loss in the year-ago quarter. But, thanks to improved sales the company raised its outlook, predicting a profit of between $21 million and $36 million for the whole year.
The company is recounting the shareholder vote for its board of directors after discovering that a tabulating firm failed to register the opposition of a major investor.
Biotechnology company ImClone Systems said on Monday that a $60-per-share takeover bid from partner Bristol-Myers Squibb was too low, but it would hire financial advisers to help it study the unsolicited offer.
The jobs data is the make or break number for markets Friday. The monthly data, reported at 8:30 a.m., is expected to show a decline of 75,000 non-farm payrolls and an unemployment rate of 5.5%.
Investor Carl Icahn, who ran a heated proxy battle to unseat the Yahoo board and oust its chief executive, said he will not be attending the Internet company's annual meeting Friday.
Sure the company and its nemesis, Carl Icahn, have joined forces so that bitter proxy contest could be eliminated. But that doesn't mean they've pushed their differences aside, or that general shareholder bitterness doesn't remain.